| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
AGA
|
aspartylglucosaminidase
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
APC
|
adenomatous polyposis coli
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
ARRB1
|
arrestin, beta 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CD177
|
CD177 molecule
|
|
CD200
|
CD200 molecule
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD99
|
CD99 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHEK2
|
checkpoint kinase 2
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
CRLS1
|
cardiolipin synthase 1
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DEK
|
DEK proto-oncogene
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ELN
|
elastin
|
|
ENG
|
endoglin
|
|
EPHA7
|
EPH receptor A7
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FBLIM1
|
filamin binding LIM protein 1
|
|
FBLN5
|
fibulin 5
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXO1
|
forkhead box O1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GPC3
|
glypican 3
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
H3F3A
|
H3 histone, family 3A
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBG1
|
hemoglobin, gamma A
|
|
HDAC6
|
histone deacetylase 6
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMHA1
|
histocompatibility (minor) HA-1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGHV3-21
|
immunoglobulin heavy variable 3-21
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL23R
|
interleukin 23 receptor
|
|
IL4
|
interleukin 4
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA1524
|
KIAA1524
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT13
|
keratin 13, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT7
|
keratin 7, type II
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LCN2
|
lipocalin 2
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR146A
|
microRNA 146a
|
|
MIR17
|
microRNA 17
|
|
MIR183
|
microRNA 183
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR34A
|
microRNA 34a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYOF
|
myoferlin
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NBN
|
nibrin
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NTN4
|
netrin 4
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
ORAOV1
|
oral cancer overexpressed 1
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
|
PARVA
|
parvin, alpha
|
|
PARVB
|
parvin, beta
|
|
PAX2
|
paired box 2
|
|
PAX3
|
paired box 3
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PPY
|
pancreatic polypeptide
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PXN
|
paxillin
|
|
RAD51
|
RAD51 recombinase
|
|
RET
|
ret proto-oncogene
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RSF1
|
remodeling and spacing factor 1
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRN
|
shadow of prion protein homolog (zebrafish)
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRIM35
|
tripartite motif containing 35
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WT1
|
Wilms tumor 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
